AnaptysBio, Inc.
ANAB$433M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO136 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
7wMarket Overview
Stock performance and key metrics
ANAB News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Rosnilimab | Phase 2 | Rheumatoid Arthritis | - | - |
Etokimab | Phase 2 | Chronic Rhinosinusitis | - | - |
Rheumatoid Arthritis
1 drug in this indication
Chronic Rhinosinusitis
1 drug in this indication
Atopic Dermatitis
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply